Download Appendix A: Disease-Specific Chapters

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts

Pandemic wikipedia , lookup

Epidemiology wikipedia , lookup

Disease wikipedia , lookup

Health system wikipedia , lookup

Health equity wikipedia , lookup

Eradication of infectious diseases wikipedia , lookup

Race and health wikipedia , lookup

Syndemic wikipedia , lookup

Reproductive health wikipedia , lookup

Preventive healthcare wikipedia , lookup

Public health genomics wikipedia , lookup

Transmission (medicine) wikipedia , lookup

International Association of National Public Health Institutes wikipedia , lookup

Infection control wikipedia , lookup

Transcript
Infectious Diseases Protocol
Appendix A:
Disease-Specific Chapters
Chapter: Severe Acute Respiratory Syndrome (SARS)
Revised January 2014
Severe Acute Respiratory Syndrome (SARS)
Communicable
Virulent
Health Protection and Promotion Act:
Ontario Regulation 558/91 – Specification of Communicable Diseases
Health Protection and Promotion Act:
Ontario Regulation 559/91 – Specification of Reportable Diseases
Health Protection and Promotion Act:
Ontario Regulation 95/03 – Specification of Virulent Diseases
1.0 Aetiologic Agent
SARS is caused by a coronavirus, called SARS-associated coronavirus (SARS-CoV) similar
on electron microscopy to animal coronaviruses.1 Coronaviruses are large, enveloped RNA
viruses.2
2.0 Case Definition
2.1 Surveillance Case Definition
See Appendix B
2.2 Outbreak Case Definition
The outbreak case definition varies with the outbreak under investigation. Consideration
should be given to the provincial surveillance case definition and the following elements
when establishing an outbreak case definition:
1.
2.
3.
4.
Clinical, laboratory and/or epidemiological information;
A time frame for occurrence;
A geographic location(s) or place(s) where cases live or became ill/exposed; and
Special attributes of cases (e.g. age, underlying conditions).
Outbreak cases may be classified by levels of probability (i.e., confirmed, probable and/or
suspect).
3.0 Identification
3.1 Clinical Presentation
SARS illness generally presents with malaise, myalgia and fever, quickly followed by
respiratory symptoms including cough and shortness of breath. Diarrhea may occur.
Symptoms may worsen for several days coinciding with viraemia at 10 days after onset.1
Nearly all confirmed infected adult cases developed pneumonia or acute respiratory distress
syndrome.2
2
3.2 Diagnosis
See Appendix B for diagnostic criteria relevant to the case definition.
Note: Serology and virology tests confirm SARS and include PCR, ELISA and IFA; clinical
specimens include clotted blood or serum for serology, nasopharyngeal swab (NPS) or NP
aspirate, bronchoalveolar lavage (BAL)/bronchial washings and stools for viral RNA
detection.
Clinical presentation and epidemiological evidence supports the diagnosis.
For further information about human diagnostic testing, contact the Public Health Ontario
Laboratories or refer to the Public Health Ontario Laboratory Services webpage:
http://www.publichealthontario.ca/en/ServicesAndTools/LaboratoryServices/Pages/default.as
px
4.0 Epidemiology
4.1 Occurrence
First recognized in February 2003; the disease is thought to have originated in the
Guangdong province of China, with emergence into human populations sometime in
November 2002. By July 2003, major outbreaks had occurred at six sites: Canada, China
(Guangdong Province, and Special Administrative Region of Hong Kong) Taiwan,
Singapore, and Viet Nam.1
The disease occurred in more than 20 additional sites throughout the world, following major
airline routes. The exposure settings for most cases were hospitals and among families and
close contacts of hospital workers.1
The last reported case of SARS occurred in China in 2004, with no evidence of SARS
coronavirus circulation in human populations since then.1
For more information on infectious diseases activity in Ontario, refer to the current versions
of the Ontario Annual Infectious Diseases Epidemiology Reports and the Monthly Infectious
Diseases Surveillance Report.3, 4
4.2 Reservoir
Identification of the SARS coronavirus has been reported from raccoons, dogs, bats and
humans.5, 6
4.3 Modes of Transmission
SARS is transmitted from person to person by close contact (i.e. within 2 metres) with
infectious respiratory secretions or body fluids of a suspected case of SARS.
The SARS virus is thought to be transmitted most readily through respiratory droplets
produced when an infected individual coughs or sneezes and possibly through fomites
(inanimate objects including surfaces or objects contaminated with infectious droplets).
In one instance, the virus is thought to have been transmitted from person to person through
some environmental vehicle, possibly aerosolised sewage or transport of sewage by
mechanical vectors.
3
4.4 Incubation Period
2-10 days (mean 5 days), with isolated reports of longer incubation periods.1
4.5 Period of Communicability
Not completely understood. Initial studies suggest that transmission does not occur before
onset of clinical signs and symptoms, and that maximum period of communicability is less
than 21 days. During the 2003 outbreak, health workers were at great risk of disease
acquisition, especially when exposed to aerosol-generating procedures such as intubations or
nebulization. In 2003, health care workers served as an entry point of the disease into the
community in North America.1
4.6 Host Susceptibility and Resistance
Unknown, but susceptibility is assumed to be universal. Race and gender do not appear to
alter susceptibility. Because of the small number of cases reported among children, it has not
been possible to assess the influence of age.1 The clinical course appears to be much milder
and shorter among cases less than 12 years of age.2
5.0 Reporting Requirements
5.1 To local Board of Health
Individuals who have or may have SARS shall be reported immediately by phone to the
medical officer of health by persons required to do so under the Health Protection and
Promotion Act, R.S.O. 1990 (HPPA).7
5.2 To the Ministry of Health and Long-Term Care (the ministry) or Public Health
Ontario (PHO), as specified by the ministry
Cases shall be reported using the integrated Public Health Information System (iPHIS), or
any other method specified by the ministry within one business day of receipt of initial
notification as per iPHIS Bulletin Number 17: Timely Entry of Cases and Outbreaks.8
For cases associated with an institution, the board of health must phone PHO, as specified by
the ministry, within 24 hours.
The minimum data elements to be reported for each case are specified in the following:
•
•
•
Ontario Regulation 569 (Reports) under the HPPA;
The iPHIS User Guides published by PHO; and,
Bulletins and directives issued by PHO.
6.0 Prevention and Control Measures
6.1 Personal Prevention Measures
Measures:
•
Since there is no SARS vaccine, the most effective measure to prevent SARS is to
prevent transmission from infected persons to susceptible persons;
4
•
•
All individuals presenting to a health care facility with symptoms of an acute respiratory
infection (ARI) should receive information about, and the importance of, respiratory
etiquette and hand hygiene; and
Ensure early recognition and prevention of transmission of SARS-CoV and other
respiratory viruses at the initial encounter with a health care facility using the assessment
protocol including travel history found in Annex B of PIDAC’s Routine Practices and
Additional Practices, Prevention of Transmission of Acute Respiratory Infection
http://www.publichealthontario.ca/en/eRepository/PIDACIPC_Annex_B_Prevention_Transmission_ARI_2013.pdf.9
6.2 Infection Prevention and Control Strategies
Strategies focus on the use of routine infection prevention and control practices in healthcare
settings and among health care workers:
•
•
All health care workers (HCWs) should be educated in regards to Routine Practices
related to infection prevention and control.
All HCWs should wear appropriate Personal Protective Equipment (PPE) when assessing
patients with suspect acute respiratory infections.9
Educate health care staff about the importance of strict adherence to, and proper use of,
routine infection prevention and control measures especially hand hygiene as well as
isolation procedures and use of appropriate PPE.9
Encourage and maintain respiratory hygiene and cough etiquette in order to reduce
transmission of all forms of respiratory pathogens, including SARS-CoV. Persons with signs
and symptoms of respiratory infection should:
•
•
•
•
Cover their nose and mouth when coughing and sneezing;
Use tissues to contain respiratory secretions;
Dispose of tissue in the nearest waste receptacle after use; and
Perform hand hygiene after contact with respiratory secretions and contaminated objects
and materials.9
Refer to Public Health Ontario’s website at www.publichealthontario.ca to search for the
most up-to-date Provincial Infectious Diseases Advisory Committee (PIDAC) best practices
on Infection Prevention and Control (IPAC). PIDAC best practice documents can be found
at:
http://www.publichealthontario.ca/en/BrowseByTopic/InfectiousDiseases/PIDAC/Pages/PID
AC_Documents.aspx.
6.3 Management of Cases
Investigate the case to determine source of infection. Refer to Section 5: Reporting
Requirements for relevant data to collect. Case detection, patient isolation and contact tracing
can reduce the number of people exposed to each infectious SARS case and break the chain
of transmission.
•
Epidemiological investigation
o Symptoms and date of symptom onset
5
o
o
o
o
o
•
Travel history
History of exposure or risk factors
Earliest and latest exposure dates
Occupational history
Residency/attendance at a facility or institution
Contact identification and tracing
o Contact history during period of communicability
o Assessment of type of contact and probability of transmission
o Identification of contacts for follow-up including patients with acute respiratory
infection (ARI) or suspected ARI
o Occupational history
o Residency/attendance at a facility or institution
While receiving institutional health care, SARS-infected cases should be placed on
"droplet/contact precautions", preferably in a single room, with a minimum of 12 air
exchanges per hour.1 Appropriate PPE should be worn and appropriate personal protective
measures performed (e.g. hand hygiene) by health care workers caring for patients infected
with SARS.
Cases should not go to work, school, or other public areas until 10 days after fever and
respiratory symptoms have resolved. During this time, infection prevention and control
precautions for SARS patients should be followed.
Refer to the PHAC document, Public Health Management of SARS Cases and Contacts
Interim Guidelines: http://web.archive.org/web/20101014152115/http://www.phacaspc.gc.ca/sars-sras/pdf/phmanagementofcases12-17_e.pdf10
6.4 Management of Contacts
A contact is a person who cared for, lived with, or had direct contact with the respiratory
secretions, body fluids and/or excretion of a probable or confirmed SARS case.1
•
Contacts should be identified and traced by determining the following:
o Patient’s contact history during period of communicability
o Assessment of type and duration of contact and probability of transmission
o Identification of contacts for follow-up including patients with acute respiratory
infection (ARI) or suspected ARI
o Occupational history
o Residency/attendance at a facility or institution
Management of asymptomatic contacts:
Contacts who were exposed but not symptomatic should be instructed to monitor themselves
for symptoms and advised of home isolation and medical evaluation if symptoms appear.
Public Health staff should stress to the contact that fever is usually the first symptom.1
Management of symptomatic contacts:
•
Immediate clinical investigation (including chest x-ray and laboratory investigation) at a
site where appropriate infection prevention and control precautions can be ensured.
6
•
Symptomatic contacts would be a probable or suspect case and would likely be
hospitalized, and
Monitor results of clinical investigation including radiographic evidence of infiltrates
consistent with pneumonia or respiratory distress and laboratory results, which may result
in a change of case status (i.e., change to “probable” or “confirmed” case or exclusion of
the case based on determination of an alternative diagnosis that can fully explain the
illness).
Refer to the PHAC document, Public Health Management of SARS Cases and Contacts
Interim Guidelines: http://web.archive.org/web/20101014152115/http://www.phacaspc.gc.ca/sars-sras/pdf/phmanagementofcases12-17_e.pdf10
6.5 Management of Outbreaks
Provide public health management of outbreaks or clusters in order to identify the source of
illness and stop the outbreak.
One confirmed case of SARS will constitute an outbreak.
As per the Infectious Diseases Protocol, 2008 (or as current) outbreak management shall
comprise of but not be limited to the following general steps:
•
•
•
•
•
•
•
•
•
•
Confirm diagnosis and verify the outbreak;
Establish an outbreak team;
Develop an outbreak case definition - These definitions should be reviewed during the
course of the outbreak, and modified if necessary, to ensure that the majority of cases are
captured by the definitions;
Implement prevention and control measures;
Implement and tailor communication and notification plans depending on the scope of the
outbreak;
Conduct epidemiological analysis on data collected;
Conduct environmental inspections of implicated premise where applicable;
Coordinate and collect appropriate clinical specimens where applicable;
Prepare a written report; and
Declare the outbreak over in collaboration with the outbreak team.
For more information on management of respiratory outbreaks, please refer to the Ontario
Agency for Health Protection and Promotion (Public Health Ontario), Provincial Infectious
Diseases Advisory Committee. Annex B – Best Practices for Prevention of Transmission of
Acute Respiratory Infection, http://www.publichealthontario.ca/en/eRepository/PIDACIPC_Annex_B_Prevention_Transmission_ARI_2013.pdf.9
7.0 References
1. Heymann DL, editor. Control of communicable diseases manual. 19th ed. Washington,
DC: American Public Health Association; 2008.
2. American Academy of Pediatrics. Section 3: summaries of infectious diseases. In:
Pickering LK, Baker CJ, Long SS, McMillan JA, editors. Red book: 2006 report of the
Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy
of Pediatrics; 2006:267-8.
7
3. Ontario. Ministry of Health and Long-Term Care. Ontario annual infectious diseases
epidemiology report, 2009. Toronto, ON: Queen’s Printer for Ontario; 2009 (or as
current) [cited 2013 Aug 27]. Available from:
http://www.health.gov.on.ca/en/common/ministry/publications/reports/epi_reports/epi_re
port_2009.aspx
4. Ontario Agency for Health Protection and Promotion (Public Health Ontario). Monthly
infectious diseases surveillance report. Toronto, ON: Queen’s Printer for Ontario; 2013
[cited 2013 Aug 27]. Available from:
http://www.publichealthontario.ca/en/ServicesAndTools/SurveillanceServices/Pages/Mo
nthly-Infectious-Diseases-Surveillance-Report.aspx
5. Understanding Evolution (homepage on the Internet). University of California Museum
of Paleontology; c2013.Tracking SARS back to its source, January 2006; 2013 Jul 1
[cited 2013 Aug 27]. Available from:
http://evolution.berkeley.edu/evolibrary/news/060101_batsars
6. Xu R-H, He J-F, Evans MR, Peng G-W, Field HE, Yu D-W, et al. Epidemiologic clues to
SARS origin in China. Emerg Infect Dis. 2004 [cited 2013 Aug 27]; 10(6):1030-7.
Available from: http://wwwnc.cdc.gov/eid/article/10/6/03-0852.htm
7. Health Protection and Promotion Act, R.S.O. 1990, c. H.7. Available from:
http://www.e-laws.gov.on.ca/html/statutes/english/elaws_statutes_90h07_e.htm.
8. Ontario. Ministry of Health and Long-Term Care. Timely entry of cases and outbreaks.
iPHIS Bulletin. Toronto, ON: Queen’s Printer for Ontario; 2012:17 (or as current).
9. Ontario Agency for Health Protection and Promotion (Public Health Ontario). ,
Provincial Infectious Diseases Advisory Committee. Annex B: Best practices for
prevention of transmission of acute respiratory infection in all health care settings.
Annexed to: Routine practices and additional precautions in all health care settings.
Toronto, ON: Queen’s Printer for Ontario; 2013 [cited 2013 Aug 27]. Available from:
http://www.publichealthontario.ca/en/eRepository/PIDACIPC_Annex_B_Prevention_Transmission_ARI_2013.pdf
10. Health Canada; National Advisory Committee on SARS and Public Health. Public health
management of SARS cases and contacts: interim guidelines. Version 7: December 17,
2003. Ottawa, ON: Health Canada; 2003 [cited 2013 Aug 27]. Available from:
http://web.archive.org/web/20101014152115/http://www.phac-aspc.gc.ca/sarssras/pdf/phmanagementofcases12-17_e.pdf
8.0 Additional Resources
Public Health Agency of Canada. Early detection of severe emerging or re-emerging
respiratory infections through severe respiratory illness (SRI) surveillance. Ottawa, ON: Her
Majesty the Queen in Right of Canada; 2006 [cited 2013 Aug 27]. Available from:
http://web.archive.org/web/20101014045621/http://www.phac-aspc.gc.ca/eri-ire/pdf/02-SRISurveillance-Protocol_e.pdf
Ontario. Ministry of Health and Long-Term Care. Infectious diseases protocol. Toronto, ON:
Queen’s Printer for Ontario; 2008 (or as current). Available from:
http://www.health.gov.on.ca/en/pro/programs/publichealth/oph_standards/infdispro.aspx
Gregg MB, editor. Field epidemiology. 2nd ed. New York, NY: Oxford University Press;
2002.
8
Centers for Disease Control and Prevention (homepage on the Internet). Atlanta, GA: Centers
for Disease Control and Prevention; c2013. Severe Acute Respiratory Syndrome (SARS);
2013 Apr 16 [cited 2009 Feb 5]. Available from: http://www.cdc.gov/sars/index.html
Health Canada; National Advisory Committee on SARS and Public Health. Learning from
SARS: renewal of public health in Canada. Ottawa, ON: Her Majesty the Queen in Right of
Canada; 2003 [cited 2013 Aug 27].
Public Health Agency of Canada (homepage on the Internet). Ottawa, ON: Her Majesty the
Queen in Right of Canada; c2004. Information for health professionals: SARS; 2004 May 5
[cited 2009 Feb 3].. Available from:
http://web.archive.org/web/20120924083507/http://www.phac-aspc.gc.ca/sars-sras/profeng.php.
Ontario. Ministry of Health and Long-Term Care, Ontario Expert Panel on SARS and
Infectious Disease Control;.For the public's health: a plan of action. Final report of the
Ontario Expert Panel on SARS and Infectious Disease Control. Toronto, ON: Queen’s
Printer for Ontario; 2004. Available from:
http://www.health.gov.on.ca/en/common/ministry/publications/reports/walker04/walker04_m
n.aspx
Ontario. Ministry of Health and Long-Term Care (homepage on the Internet). Toronto, ON:
Queen’s Printer for Ontario; c2003. Severe Acute Respiratory Syndrome (SARS) Archive;
2003 [cited 2009 Feb 15]. Available from:
http://web.archive.org/web/20090701002626/http://www.health.gov.on.ca/english/providers/
program/pubhealth/sars/sars_ar.html
Health Canada. Health Canada’s preparedness for and response to respiratory infections
season and the possible re-emergence of SARS: Fall/winter 2003/04 as of Nov 19/03.
Ottawa, ON: Health Canada; 2003 [cited 2013 Aug 27]. Available from:
http://web.archive.org/web/20101014125952/http://www.phac-aspc.gc.ca/sars-sras/rissir/pdf/hc-pr-ris-sars.pdf
Campbell A; Commission to Investigate the Introduction and Spread of Severe Acute
Respiratory Syndrome (SARS). The SARS commission final report: spring of fear. Toronto,
ON: Queen’s Printer for Ontario; 2006 [cited 2013 Aug 27]. Available from:
http://www.archives.gov.on.ca/en/e_records/sars/report/
Ontario. Ministry of Health and Long-Term Care (homepage on the Internet). Toronto, ON:
Queen’s Printer for Ontario; c2004. Health update. SARS: Severe Acute Respiratory
Syndrome; 2004 [cited 2009 Feb 11]. Available from:
http://web.archive.org/web/20120417212652/http://www.health.gov.on.ca/english/public/upd
ates/archives/hu_03/hu_sars.html
Kamps BS, Hoffmann C. SARS Reference – 10/2003. 3rd ed. Flying Publisher; 2003 [cited
2013 Aug 27]. Available from: http://www.sarsreference.com/sarsreference.pdf.
9
9.0 Document History
Table 1: History of Revisions
Revision Date
January 2014
Document Section
General
Description of Revisions
New template.
Section 9.0 Document History Added.
Title of Section 4.5 changed from
“Susceptibility and Resistance” to “Host
Susceptibility and Resistance”
Title of Section 5.2 changed from “To Public
Health Division (PHD)” to “To the Ministry of
Health and Long-Term Care (the ministry) or
Public Health Ontario (PHO), as specified by the
ministry”
3.2 Diagnosis
Clinical specimens updated.
Addition of direction to contact Public Health
Ontario Laboratories or PHO website for
additional information on human diagnostic
testing.
4.1 Occurrence
Third paragraph revised to indicate that the last
reported case of SARS occurred in China in
2004.
Fourth paragraph revised to refer to the Ontario
Annual Infectious Diseases Epidemiology
Reports and the Monthly Infectious Diseases
Surveillance Report for more information.
4.2 Reservoir
Changed from “unknown” to “Identification of
the SARS coronavirus has been reported from
raccoons, dogs, bats and humans”.
4.3 Modes of
Transmission
Close contact changed from “within 1 to 2
metres” to “within 2 metres”.
4.4 Incubation Period
Changed from “3 – 10 days” to “2-10 days
(mean 5 days), with isolated reports of longer
incubation periods”.
6.2 Infection
Prevention and
Control Strategies
Addition of reference to PIDAC IPAC best
practices documents.
6.3 Management of
Cases
First sentence of fourth paragraph changed from
“While receiving institutional health care,
SARS-infected cases should be placed on
10
Revision Date
Document Section
Description of Revisions
droplet precautions.” to “While receiving
institutional health care, SARS-infected cases
should be placed on "droplet/contact
precautions", preferably in a single room,
with a minimum of 12 air exchanges per
hour”.
The following two paragraphs were deleted:
“There are no specific treatment
recommendations for SARS. (The
application of intensive supportive
therapy and empirical antimicrobial
therapy, to cover other infective agents is
the usual approach).”
“While ribavirin, corticosteroids,
oseltamivir, protease inhibitors and other
medications have been used in the
treatment of SARS, thus far there is no
consensus on an optimal treatment
regimen.”
First sentence of fifth paragraph changed from
“Cases should not go to work, school, or other
public areas until 10 to 14 days after fever and
respiratory symptoms have resolved” to “Cases
should not go to work, school, or other public
areas until 10 days after fever and respiratory
symptoms have resolved”.
.
6.4 Management of
Contacts
Section on identification and tracing of contacts
revised.
Section on management of asymptomatic
contacts revised.
6.5 Management of
Outbreaks
Outbreak definition changed from “One
suspected, probable or confirmed case of SARS
will constitute an outbreak” to “One confirmed
case of SARS will constitute an outbreak”.
7.0 References
Updated.
8.0 Additional
Resources
Updated.
11
© 2014 Queen’s Printer for Ontario